Sign in

    Joe Kim

    Senior Research Analyst at Water Tower Research

    Joe Kim is a Senior Research Analyst at Water Tower Research, focusing on innovative growth companies with a specialization in the healthcare technology sector. He has covered companies such as Ainos, participating in investor events and fireside chats that foster direct dialogue with company leadership and investors. With multiple years of experience in equity research, Joe joined Water Tower Research after building his analytical expertise in related research roles. He maintains professional credentials critical for securities research, including relevant FINRA registrations and analyst certifications.

    Joe Kim's questions to AWH leadership

    Joe Kim's questions to AWH leadership • Q1 2024

    Question

    Asked about the recommended frequency for Longitudinal Monitoring with OvaWatch, any reimbursement limits on testing frequency, the marketing strategy for the new publications, and the current landscape for endometriosis diagnosis, including the overlap with their current sales efforts.

    Answer

    The company stated that the frequency of OvaWatch repeat testing is left to physician discretion, with no current reimbursement limits. The new publications are being actively marketed through the sales force, inside sales, and KOL events. Regarding endometriosis, the diagnostic landscape still relies on invasive surgery, and there is a significant overlap in the target physician audience with OvaSuite, along with strong, pre-existing patient demand for better diagnostics.

    Ask Fintool Equity Research AI